17th week of 2021 patent applcation highlights part 9 |
Patent application number | Title | Published |
20210121526 | PEPTIDES DERIVED FROM KITA-KYUSHU LUNG CANCER ANTIGEN (KKLC1, CT83, CXORF61) AND COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES | 2021-04-29 |
20210121527 | METHODS OF TREATING MINIMAL RESIDUAL CANCER | 2021-04-29 |
20210121528 | COMPOSITIONS FOR TREATING LUNG INFECTIONS BY AIRWAY ADMINISTRATION | 2021-04-29 |
20210121529 | STABLE HYBRID FC FUSION G-CSF FORMULATION | 2021-04-29 |
20210121530 | METHODS AND COMPOSITIONS FOR REGULATING INNATE LYMPHOID CELL INFLAMMATORY RESPONSES | 2021-04-29 |
20210121531 | MODULATING RESPONSES TO CHECKPOINT INHIBITOR THERAPY | 2021-04-29 |
20210121532 | USE OF INTERLEUKIN 2 FOR TREATING SJOGREN'S SYNDROME | 2021-04-29 |
20210121533 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH IL-10 OR AN IL-10 AGONIST | 2021-04-29 |
20210121534 | SUSTAINED-RELEASE DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A CNP COMPOUND, AN NPR-B COMPOUND, A TIE-2 AGONIST, OR NEUROTROPHIC AGENT FOR USE FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION | 2021-04-29 |
20210121535 | METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR | 2021-04-29 |
20210121536 | METHODS AND COMPOSITIONS COMPRISING SURFACTANT PROTEIN D (SP-D) | 2021-04-29 |
20210121537 | Methods and Compositions for Treating Phenylketonuria | 2021-04-29 |
20210121538 | Interactional Biosystem | 2021-04-29 |
20210121539 | METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION | 2021-04-29 |
20210121540 | NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYME | 2021-04-29 |
20210121541 | CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological Disorders | 2021-04-29 |
20210121542 | COMPOSITION FOR DELIVERY OF PROTEIN THERAPEUTICS THROUGH ORAL, SUBLINGUAL AND BUCCAL ROUTE | 2021-04-29 |
20210121543 | SUTURE LINE ADMINISTRATION TECHNIQUE USING BOTULINUM TOXINS | 2021-04-29 |
20210121544 | Polypeptide with Asparaginase Activity, Expression Cassette, Expression Vector, Host Cell, Pharmaceutical Composition, Methods for Producing a Polypeptide with Asparaginase Activity and for Preventing or Treating Cancer, and Use of a Polypeptide | 2021-04-29 |
20210121545 | TOXOPLASMA GONDII VACCINE | 2021-04-29 |
20210121546 | COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS | 2021-04-29 |
20210121547 | PROGESTERONE-ASSOCIATED ENDOMETRIAL PROTEIN (PAEP) AND USES THEREOF | 2021-04-29 |
20210121548 | COMPOSITIONS FOR ACTIVE CELLULAR IMMUNOTHERAPY OF CANCER BY USING TUMOR CELLS KILLED BY HIGH HYDROSTATIC PRESSURE AND DENDRITIC CELLS | 2021-04-29 |
20210121549 | METHODS FOR TREATING NETOSIS AND NEUTROPHIL ACTIVATION | 2021-04-29 |
20210121550 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | 2021-04-29 |
20210121551 | PEPTIDES DERIVED FROM MELANOMA-ASSOCIATED ANTIGEN C2 (MAGEC2) AND USES THEREOF | 2021-04-29 |
20210121552 | Composition, Preparation Method And Evaluation Of A Complex Immunogen Named I-SPGA For Production Of Immunological Active Proteins (IAP) | 2021-04-29 |
20210121553 | Enhanced Shigella-Enterotoxigenic E. coli multi-valent vaccine | 2021-04-29 |
20210121554 | ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF | 2021-04-29 |
20210121555 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | 2021-04-29 |
20210121556 | OPTIMIZED EPICUTANEOUS VACCINATION | 2021-04-29 |
20210121557 | NOVEL SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS | 2021-04-29 |
20210121558 | COMPOSITIONS AND METHODS FOR STABILIZING FLAVIVIRUSES WITH IMPROVED FORMULATIONS | 2021-04-29 |
20210121559 | METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS | 2021-04-29 |
20210121560 | Vaccines For Human Papilloma Virus And Methods For Using The Same | 2021-04-29 |
20210121561 | METHODS OF PRODUCING CELLS RESISTANT TO HIV INFECTION | 2021-04-29 |
20210121562 | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2021-04-29 |
20210121563 | COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND USES THEREOF | 2021-04-29 |
20210121564 | COMBINING ADENOVIRUS AND CHECKPOINT INHIBITORS FOR TREATING CANCER | 2021-04-29 |
20210121565 | Combination Therapy | 2021-04-29 |
20210121566 | LIQUID PHARMACEUTICAL COMPOSITION | 2021-04-29 |
20210121567 | PROTEIN FORMULATIONS AND METHODS OF MAKING SAME | 2021-04-29 |
20210121568 | GASTROINTESTINAL TRACT THERAPEUTIC AGENTS | 2021-04-29 |
20210121569 | NANOTHERAPEUTIC SYSTEMS AND METHODS USING PARTICLE-DRIVEN PHOTODYNAMIC THERAPY (PDT) | 2021-04-29 |
20210121570 | METHOD | 2021-04-29 |
20210121571 | METHODS OF REDUCING AGGREGATION OF IL-1RA | 2021-04-29 |
20210121572 | COMPOSITIONS AND METHODS FOR TREATING DISEASES OF THE NAIL | 2021-04-29 |
20210121573 | ABSORPTION ENHANCERS FOR DRUG ADMINISTRATION | 2021-04-29 |
20210121574 | SUSTAINED RELEASE OF ANTIINFECTIVES | 2021-04-29 |
20210121575 | Poloxamer Compositions With Reduced Sol-Gel Transition Temperatures and Methods of Reducing the Sol-Gel Transition Temperature of Poloxamer Compositions | 2021-04-29 |
20210121576 | DERMOCOSMETIC COMPOSITIONS INCLUDING GLYCEROL-SEBACATE | 2021-04-29 |
20210121577 | FILM COATED TABLET FOR THE TREATMENT OF ACUTE PAIN | 2021-04-29 |
20210121578 | LUNG SURFACTANT-BASED ANTICANCER DRUG | 2021-04-29 |
20210121579 | GENE THERAPY | 2021-04-29 |
20210121580 | Functionalized DNA Dendrimers For Gene Delivery To Cells | 2021-04-29 |
20210121581 | METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS | 2021-04-29 |
20210121582 | INDICATOR COMPOUNDS, DEVICES COMPRISING INDICATOR COMPOUNDS, AND METHODS OF MAKING AND USING THE SAME | 2021-04-29 |
20210121583 | METHODS OF SCREENING FOR SORTILIN BINDING ANTAGONISTS | 2021-04-29 |
20210121584 | TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES | 2021-04-29 |
20210121585 | PSMA targeted radiotherapy medicine and preparation method thereof | 2021-04-29 |
20210121586 | SYSTEMS, METHODS, AND DEVICES FOR STERILIZING ANTISEPTIC SOLUTIONS | 2021-04-29 |
20210121587 | Integrated intracavity gas circulation treatment device for laparoscopic surgery | 2021-04-29 |
20210121588 | SYSTEMS AND METHODS FOR SANITIZING AMUSEMENT PARK EQUIPMENT | 2021-04-29 |
20210121589 | DISINFECTION SYSTEM FOR WOOD BARRELS | 2021-04-29 |
20210121590 | APPARATUS, PROBE ASSEMBLY AND METHODS FOR TREATING CONTAINERS | 2021-04-29 |
20210121591 | METHOD OF LIMITING THE SPREAD OF NOROVIRUS WITHIN A CRUISE SHIP | 2021-04-29 |
20210121592 | DUAL DECONTAMINATION MECHANISM DEVICE | 2021-04-29 |
20210121593 | GREEN BIN ODOR REDUCTION COMPOSITION AND USE THEREOF | 2021-04-29 |
20210121594 | ELECTRONIC SCENTED CANDLE AND FRAGRANCE CONTAINER | 2021-04-29 |
20210121595 | TEXTILE PART | 2021-04-29 |
20210121596 | Menstrual tampon | 2021-04-29 |
20210121597 | Therapeutic Compositions for Enhanced Healing of Wounds and Scars | 2021-04-29 |
20210121598 | Biomedical Foam | 2021-04-29 |
20210121599 | COMPOSITIONS I - I AND PRODUCTS AND USES THEREOF | 2021-04-29 |
20210121600 | Skin Closure Devices with Self-Forming Exudates Drainage Channesl | 2021-04-29 |
20210121601 | METHODS FOR TREATING WOUNDS | 2021-04-29 |
20210121602 | READY-TO-USE ESTHETIC COMPOSITIONS | 2021-04-29 |
20210121603 | INJECTABLE, BIOADHESIVE CRYOGEL SCAFFOLDS FOR BIOMEDICAL USES | 2021-04-29 |
20210121604 | BIOENGINEERED WHARTON'S JELLY DERIVED EXTRACELLULAR MATRIX | 2021-04-29 |
20210121605 | Preparation method of gradient mineralized cancellous bone matrix material | 2021-04-29 |
20210121606 | IONIC-DOPED COMPOSITION METHODS AND USES THEREOF | 2021-04-29 |
20210121607 | Implantable Device Having an Outer Surface Comprising Gold and Its Use as an Anti-Migration Device | 2021-04-29 |
20210121608 | WOUND THERAPY DEVICE PRESSURE MONITORING AND CONTROL SYSTEM | 2021-04-29 |
20210121609 | SYSTEMS AND METHODS FOR APPLYING REDUCED NEGATIVE PRESSURE THERAPY | 2021-04-29 |
20210121610 | CHEST DRAINAGE SYSTEMS AND METHODS | 2021-04-29 |
20210121611 | Systems for Removing Air from the Fluid Circuits of a Plasma Processing System | 2021-04-29 |
20210121612 | Systems for Removing Air from the Fluid Circuits of a Plasma Processing System | 2021-04-29 |
20210121613 | Breast Pumping System | 2021-04-29 |
20210121614 | BREASTPUMP | 2021-04-29 |
20210121615 | Breast Pumping System | 2021-04-29 |
20210121616 | MANUAL BREAST PUMP | 2021-04-29 |
20210121617 | CIRCULATORY SUPPORT SYSTEMS INCLUDING CONTROLLER AND PLURALITY OF SENSORS AND METHODS OF OPERATING SAME | 2021-04-29 |
20210121618 | Low Resistance Microfabricated Filter | 2021-04-29 |
20210121619 | ARTIFICIAL KIDNEY | 2021-04-29 |
20210121620 | WORKING FLUID TREATMENT DEVICE FOR MASS TRANSFER BETWEEN A WORKING FLUID AND TWO FLUID EXCHANGE MEDIA | 2021-04-29 |
20210121621 | Packaging for Medical Containers | 2021-04-29 |
20210121622 | INTRAVENOUS (IV) TUBE ORGANIZATION AND LABELING APPARATUS AND SYSTEM | 2021-04-29 |
20210121623 | CONTROLLER, METHOD FOR CONTROLLING CONTROLLER, LEARNING DEVICE, AND STORAGE MEDIUM | 2021-04-29 |
20210121624 | IMPLANTABLE INFUSION DEVICES WITH CLOSED LOOP SENSING AND ASSOCIATED METHODS | 2021-04-29 |
20210121625 | Methods and Compositions for Treating a Disease Condition in a Subject | 2021-04-29 |